Vincerx Pharma Inc.
13F holders, Q1 2024 (March 31)38holders
4famous investors
$5.05avg. 13F price*
At the end of Q1 2024, 38 institutions reported holding Vincerx Pharma Inc. in their 13F filings. The largest holders were Sage Rhino Capital LLC ($8.6M), Octagon Capital Advisors LP ($5.1M) and Point72 Asset Management ($4.8M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Vincerx Pharma Inc.
- CUSIP
- 92731L106
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $6.4M |
| Exits | 6 | $1.9M |
Ownership 38 holders
| Sage Rhino Capital LLC | 2.03% | No change | 1,703,413 | $8.6M |
| Octagon Capital Advisors LP | 0.62% | New | 1,000,000 | $5.1M |
| Point72 Asset Management | 0.01% | Add +176.9% | 954,827 | $4.8M |
| Rock Springs Capital Management LP | 0.12% | No change | 891,719 | $4.5M |
| Bank of America Corp. | 0.00% | Reduce -35.2% | 701,423 | $3.5M |
| Vanguard Group Inc. | 0.00% | Add +29.9% | 666,995 | $3.4M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -63.1% | 631,490 | $3.2M |
| Kingdon Capital Management, L.L.C. | 0.26% | No change | 385,000 | $1.9M |
| ExodusPoint Capital Management, LP | 0.02% | Reduce -2.3% | 316,642 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Add +18.5% | 182,483 | $924K |
| Citadel Advisors | 0.00% | Reduce -9.7% | 178,240 | $902K |
| Renaissance Technologies | 0.00% | Reduce -31.0% | 121,400 | $614K |
| Rubric Capital Management LP | 0.02% | Reduce -67.0% | 116,873 | $591K |
| Sio Capital Management, LLC | 0.18% | No change | 102,049 | $516K |
| Eversept Partners, LP | 0.03% | New | 79,588 | $403K |
| Marshall Wace, LLP | 0.00% | New | 71,566 | $362K |
| State Street Corp. | 0.00% | Add +32.2% | 57,016 | $289K |
| BlackRock Inc. | 0.00% | Reduce -26.7% | 47,080 | $238K |
| Northern Trust Corp. | 0.00% | Add +34.0% | 34,325 | $174K |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -25.0% | 30,000 | $152K |
| Jane Street Group, LLC | 0.00% | New | 29,318 | $148K |
| Millennium Management | 0.00% | Reduce -24.7% | 25,944 | $131K |
| Woodline Partners LP | 0.00% | New | 23,645 | $120K |
| Morgan Stanley | 0.00% | Add +10.5% | 19,627 | $99K |
| Vontobel Holding Ltd. | 0.00% | New | 15,000 | $76K |
| LPL Financial LLC | 0.00% | New | 13,770 | $70K |
| American Century Companies Inc. | 0.00% | New | 11,789 | $60K |
| LMR Partners LLP | 0.00% | No change | 10,000 | $51K |
| Cresset Asset Management, LLC | 0.00% | New | 10,000 | $51K |
| Acadian Asset Management LLC | 0.00% | Reduce -87.4% | 5,259 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -15.1% | 4,541 | $23K |
| UBS Group AG | 0.00% | Reduce -15.3% | 2,498 | $13K |
| Qube Research & Technologies Ltd | 0.00% | Add +61825.0% | 2,477 | $13K |
| Focus Partners Wealth | 0.00% | New | 10,900 | $10K |
| ICA Group Wealth Management, LLC | 0.00% | New | 300 | $2K |
| Wells Fargo & Company | 0.00% | Add +20.3% | 160 | $810 |
| Barclays PLC | 0.00% | No change | 23 | $116 |
| Macquarie Group Ltd. | 0.00% | New | 266 | $1 |
"% of holder's portfolio" is VINCERX PHARMA INC's weight in each manager's 13F, not the share of Vincerx Pharma Inc. the manager owns.